2018年美国儿科学会减少阿片类药物处方挑战前后小儿泌尿外科手术全国术后阿片类药物处方率:索赔数据库分析
该研究基于TriNetX研究数据库,纳入81,644例18岁以下接受七种常见小儿泌尿外科手术的患者,评估术后5天内口服阿片类药物处方率。结果显示,2018年美国儿科学会挑战声明发布前,处方率每3个月间隔上升0.9%,发布后每3个月间隔显著下降2.2%;但总体处方率仍高,并存在潜在的种族或年龄差异,需进一步调查。
要点
- 81,644例小儿泌尿外科手术中,29,595例(36.2%)接受术后阿片类药物处方。
- 挑战声明发布前,阿片类药物处方率每3个月间隔上升0.9%;发布后每3个月间隔显著下降2.2%。
- 2018年后,所有种族、民族和年龄队列的阿片类药物处方均显著下降,但处方率仍高,存在潜在种族或年龄差异。
核心结论
- 2018年美国儿科学会挑战声明发布后,小儿泌尿外科手术术后阿片类药物处方率急剧下降,凸显了跨专业质量改进举措的价值;但处方率仍高,存在潜在的种族或年龄差异,需进一步调查。
研究设计与样本
- 基于TriNetX研究数据库的索赔数据库分析,纳入81,644例18岁以下接受七种常见小儿泌尿外科手术的患者。
- 主要分析采用2010年1月至2022年12月的3个月间隔评估术后阿片类药物处方趋势,并进行中断时间序列分析评估美国儿科学会挑战声明前后的处方模式趋势。
主要发现
- 81,644例小儿泌尿外科手术中,29,595例(36.2%)接受术后阿片类药物处方,包括29.8%的包皮环切术、25.8%的鞘膜积液切除术、39.6%的尿道下裂修复术、42.7%的肾盂成形术、42.8%的输尿管再植入术。
- 2010年至2018年挑战声明发布前,所有手术的阿片类药物处方率每3个月间隔上升0.9%。
- 挑战声明发布后,阿片类药物处方总体每3个月间隔显著下降2.2%。
- 自2018年以来,所有种族、民族和年龄队列的阿片类药物处方均显著下降。
局限性
- 原文指出处方率仍高,存在潜在的种族或年龄差异,需进一步调查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate trends in opioid prescribing rates following pediatric urologic surgery. METHODS: We queried the TriNetX Research database for patients under age 18 who underwent one of seven common pediatric urology procedures. We identified the proportion of patients that received an oral opioid prescription within 5days of surgery. The primary analysis evaluated the trend in postoperative opioid prescriptions using 3-month intervals from January 2010 to December 2022. We performed an interrupted time series analysis assessing trends in opioid prescribing patterns both before and after the American Academy of Pediatrics challenge. RESULTS: Of the 81,644 pediatric urology procedures, 29,595 (36.2%) received a postoperative opioid prescription, including 29.8% of circumcisions, 25.8% of hydrocelectomies, 39.6% of hypospadias repairs, 42.7% of pyeloplasties, 42.8% of ureteral reimplants. For all procedures we observed rising rates of opioid prescribing, increasing by 0.9% per 3-month interval prior to the challenge statement release from 2010 to 2018. We observed an overall significant decrease in opioid prescribing by 2.2% per 3-month interval following the challenge statement release. Additionally, since 2018, there was a significant decrease in opioid prescribing in all of the race, ethnicity, and age cohorts. CONCLUSION: Opioid prescribing following pediatric urology procedures has sharply decreased following the 2018 American Academy of Pediatrics challenge statement which underscores the value of cross-specialty quality improvement initiatives. Nonetheless, opioid prescribing remains high with potential racial or age disparities that warrant further investigation.
引用
- Able C, Stewart C, Gabrielson AT, et al. National Postoperative Opioid Prescribing Rates Following Pediatric Urology Procedures Before and After the 2018 American Academy of Pediatrics Challenge to Reduce Opioid Prescribing: A Claims Database Analysis. Urology. 2023. PMID: 38043907. doi:10.1016/j.urology.2023.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。